CTOs on the Move

Canadian Association of Gastroenterology

www.cag-acg.org

 
Canadian Association of Gastroenterology is a Oakville, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.cag-acg.org
  • 2902 South Sheridan Way
    Oakville, ON CAN L6J 7L6
  • Phone: 905.829.2504

Executives

Name Title Contact Details

Similar Companies

Texas American Title Company

Texas American Title Company is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in New York, NY. To find more information about Texas American Title Company, please visit www.texasamerican.com

Audiotech Healthcare Corporation

Audiotech Healthcare Corporation is a Salmon Arm, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Field Trip Health

At Field Trip, we are redefining mental health and well-being through ground-breaking work in psychedelics and psychedelic-enhanced psychotherapy. With Field Trip Health centres opening across North America, and drug development and advanced research on plant-based psychedelics through Field Trip Discovery, we help people to heal and heighten engagement with the world.

Delta Health Systems

Delta Health Systems is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Cleveland Biolabs

Cleveland BioLabs, Inc. (NASDAQ: CBLI) is an innovative bio pharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. Our proprietary platform of toll-like immune receptor activators has applications in radiation mitigation, oncology immunotherapy, and vaccines. We combine our proven scientific expertise and our depth of knowledge about our products’ mechanisms of action into a passion for developing drugs to save lives. Our proprietary drug candidates act via unique mechanisms that are designed to kill cancer and protect healthy cells. Our most advanced product candidate is entolimod, which we are developing as a radiation countermeasure and an immunotherapy for oncology and other indications. We have additional pipeline product candidates in various stages of development.